On Nov. 15, the Trump administration released two rules — one final, one proposed — outlining new price transparency requirements for hospitals and health insurers, which the industry has long warned will impede competitive rate negotiations without actually benefiting patients. But while legal challenges could delay or even prevent those rules from being implemented, that doesn’t mean health care organizations have nothing to worry about.
To access this post, you must purchase a subscription plan. Click Here to purchase.

Already a member? Click Here to login.